Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC
Pathogens · 28.01.2024 · 13 (2) · 124
DOI: 10.3390/pathogens13020124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 28.01.2024. Verfasst von Elisabeth W Andersen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA. Hauptthemen laut MEDLINE: HIV Infections, Health Knowledge, Attitudes, Practice, Vaccination. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Allergy and Infectious Diseases of the National Institutes of Health.
Abstract (Originalsprache)
People with HIV (PWH) are disproportionally affected by mpox and at risk of severe complications. We assessed mpox knowledge, adoption of preventive behaviors, and vaccination attitudes among PWH enrolled in a longitudinal HIV cohort in Washington, DC, the DC Cohort. We conducted uni- and multivariable analyses comparing participants by vaccination status and HIV risk group, and multinomial regression to identify factors associated with vaccine acceptance. Among 430 PWH, 378 (87.9%) were aware of mpox. Among 373 participants with vaccination status data, 101 (27.1%) were vaccinated, 129 (34.6%) planned to vaccinate, and 143 (38.3%) did not plan to vaccinate. The three vaccination groups differed significantly by age, race, education, HIV risk group, recent STI status, and level of mpox worry (all p < 0.05). A higher proportion of men who have sex with men (MSM) reported limiting their number of sexual partners compared to non-MSM (p < 0.0001). Multinomial regression models comparing vaccinated to unvaccinated PWH found age, education, mode of HIV transmission/gender, and survey period were significantly associated with vaccination status (all p < 0.05). High levels of mpox awareness were observed among this cohort of PWH with more MSM employing risk reduction behaviors and being vaccinated. Ensuring that PWH, regardless of gender, sexual orientation, or age, understand the risks of mpox may improve vaccination uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052, USA.
- Division of Infectious Diseases, The George Washington School of Medicine and Health Sciences, Washington, DC 20052, USA.
- The Washington DC Veterans Affairs Administration, Washington, DC 20422, USA.
ORCID-Profile: Paige Kulie, Amanda D Castel, Anne Monroe
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Allergy and Infectious Diseases of the National Institutes of Health
Zitieren
APA
Andersen, E. W., Kulie, P., Castel, A. D., Lucar, J., Benator, D., Greenberg, A. E., Monroe, A., & DC Cohort Executive Committee (2024). Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC. Pathogens, 13(2), 124. https://doi.org/10.3390/pathogens13020124
Vancouver
Andersen EW, Kulie P, Castel AD, Lucar J, Benator D, Greenberg AE, et al. Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC. Pathogens. 2024;13(2):124. doi:10.3390/pathogens13020124
BibTeX
@article{Andersen2024,
author = {Andersen, Elisabeth W and Kulie, Paige and Castel, Amanda D and Lucar, Jose and Benator, Debra and Greenberg, Alan E and Monroe, Anne and DC Cohort Executive Committee, DC Cohort Executive Committee},
title = {Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {2},
pages = {124},
doi = {10.3390/pathogens13020124}
}
EUVIMED